From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: I am now over 10%, keep pledging

By Tom Winnifrith | Saturday 10 May 2025


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


In today's bearcast I look at Optibiotix (OPTI), the standing of the London markets and the prospectus exemption scandal that needs addressing to stop rogues like Hemogenyx (HEMO), Genflow (GENF) and Predator Oil & Gas (PRD) duping shareholders. I am writing to the FCA about this matter this weekend. 
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

CLAI

CelAI madness begets madness

Monday »

ICON

Iconic Labs, the world has gone mad!

Time left: 00:13:14